Hearing Impairment of Nasopharyngeal Carcinoma
NCT05330169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-07-17
Summary
This observational cohort study was aimed to evaluate the hearing toxicity at multiple time points from baseline to 1 year after radical chemoradiotherapy among nasopharyngeal carcinoma patients.
Conditions
- Nasopharyngeal Carcinoma
Sponsors & Collaborators
-
Guangxi Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2022-12-31
- Completion
- 2023-12-31
Countries
- China
Study Locations
More Related Trials
-
Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy
NCT01102621 ·Status: COMPLETED
-
Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma
NCT05039606 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer
NCT03559803 ·Status: UNKNOWN ·Phase: NA
-
Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma (neoHNSCC)
NCT06011993 ·Status: UNKNOWN
-
Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC
NCT05351762 ·Status: UNKNOWN ·Phase: PHASE2
-
Change in Symptom Clusters in HNC Patients
NCT03356093 ·Status: COMPLETED
-
The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma
NCT05831930 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
NCT06957938 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
NCT03225157 ·Status: COMPLETED
-
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
NCT05494190 ·Status: RECRUITING ·Phase: NA
-
Ovarian Function of Nasopharyngeal Carcinoma Women Survivors
NCT05183724 ·Status: NOT_YET_RECRUITING
-
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
NCT02301208 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT06100497 ·Status: RECRUITING ·Phase: PHASE2
-
the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer
NCT03196869 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT03427359 ·Status: COMPLETED ·Phase: PHASE2
-
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
NCT04319471 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer
NCT05863377 ·Status: UNKNOWN
-
Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC
NCT05459415 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)
NCT03639168 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC
NCT06793761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
NCT06929468 ·Status: NOT_YET_RECRUITING
-
Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer
NCT01609114 ·Status: UNKNOWN
-
GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma
NCT01655628 ·Status: UNKNOWN ·Phase: PHASE2
-
Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma
NCT03701451 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial
NCT04502641 ·Status: UNKNOWN ·Phase: PHASE3